BELLEVUE, Wash., Oct. 18, 2022 (GLOBE NEWSWIRE) -- EMulate Therapeutics, a clinical-stage, life sciences, digital therapeutics company developing safe, non-invasive, and highly effective treatments ...

Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System , a self-contained instrument that cultures, incubates, and images up ...

Platform adopted by 10 of the top 25 biopharmaceutical companies, by U.S. governmental agencies, and by academic research centers worldwide Organs-on-Chips enable drug developers and researchers to ...

Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...

This article was first published in the May 2016 issue of WIRED magazine. Be the first to read WIRED's articles in print before they're posted online, and get your hands on loads of additional content ...

Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...

The human guinea pig may soon be extinct. He (it’s usually a ‘he’) has become endangered through the advances of cell culture science, which increasingly close the gap between in vitro testing (the ...

Emulate, Inc. today announced the company’s launch with a $12 million Series A financing to commercialize a first-in-kind, automated ‘Organs-on-Chips’ platform that mimics human physiology and ...

Who will come up with the killer app for drug discovery, the thing that will make finding new medicines faster, cheaper, and less risky? No one has come close to figuring that out, but a group of ...

Researchers used real-world clinical data to attempt to emulate a randomized controlled trial testing the effectiveness of two blood thinners, apixaban and warfarin, to prevent stroke in patients with ...